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Cell fueling and metabolic energy conservation in synthetic cells 
Hendrik R. Sikkema[a], Bauke F. Gaastra[a], Tjeerd Pols[a] and Bert Poolman*[a]  
Abstract: We aim for a blue print for synthesizing (moderately 
complex) subcellular systems from molecular components and 
ultimately for constructing life. Without comprehensive instructions 
and design principles we rely on simple reaction routes to operate 
the essential functions of life. The first forms of synthetic life will not 
make every building block for polymers de novo via complex 
pathways, rather they will be fed with amino acids, fatty acids and 
nucleotides. Controlled energy supply is crucial for any synthetic cell, 
no matter how complex. Here, we describe the simplest pathways 
for efficient generation of ATP and electrochemical ion gradients. We 
estimated the demand for ATP by polymer synthesis and 
maintenance processes in small cell-like systems, and we describe 
circuits to control the needs for ATP. We also present fluorescence-
based sensors for pH, ionic strength, excluded volume, ATP/ADP, 
and viscosity, which allow monitoring and tuning of the major 
physicochemical conditions inside cells. 
1. Introduction 
“Life is not just about replication; it is also a coupling of 
chemical reactions – exergonic ones that release 
energy and endergonic ones that utilise it, preventing 
the dissipation of energy as heat”. [1] 
 
“What is life” is one of the most intriguing and difficult questions 
to answer, even at the cellular scale. At the molecular level, 
however, it is well established that life is a system of self-
sustained chemical processes. Biochemical networks direct cell 
growth and division, and through the uptake of nutrients, the 
conservation of metabolic energy and the excretion of waste, 
they maintain a dynamic state far from thermodynamic 
equilibrium. Other features of life-like systems are that they are 
kinetically controlled (orchestrated through feedback loops), self-
organized and compartmentalized, which enables active, 
adaptive and autonomous behavior. Such properties are present 
even in the simplest forms of life.  
 
The prospect of creating synthetic life has inspired people for 
many years. The Venter Institute, for instance, has 
demonstrated that a de novo synthesized genome containing 
less than 500 genes can lead to viable cells.[2,3] While creating a 
reduced cell by selectively removing components from a wild-
type genome is an impressive achievement, this top-down 
approach leads to a minimal cell with a reduced set of 
biomolecules, but it does not reveal how the remaining gene 
products act together to create life, nor does it capture the links 
between metabolism, compartmentalization and the information 
contained in DNA. As a result, it has not yet been possible to 
rationally design and construct, using a bottom-up constructive 
approach, a simple form of life based on a limited number of 
molecular building blocks (see e.g. ref [4]). While our 
fundamental understanding of the individual building blocks of 
life is rapidly growing, putting a minimal set of components 
together such that life-like properties emerge remains a 
formidable, yet exciting challenge.  
 
In our view, true understanding of “molecular life” requires the 
design and synthesis from scratch of systems with increasing 
complexity. This bottom-up assembly using molecular 
components has been referred to as synthetic biochemistry.[5] 
Fostered by the fields of biophysics and biochemistry and the 
need for quantitative studies of molecular building blocks, there 
has been rapid progress in the reconstitution and quantitative 
understanding of complex biological systems and processes, 
such as: complex membranes and transport systems[6], 
sophisticated DNA processing machineries[7,8], complex 
cytoskeletal systems[9], self-organized spatial protein patterns[10] 
and cell-free gene expression[11]. In addition, the possibilities for 
genome engineering have exploded with the development of 
powerful DNA assembly methods and the CRISPR.[12,13] 
 
In the first part of this paper, we focus on the construction of cell-
like systems from molecular building blocks, that is, the 
assembly and engineering of the components that enable a cell-
like system to form ATP and generate electrochemical ion 
gradients and achieve energy homeostasis. This is one of the 
crucial networks that is essential for any life-like system as cells 
need both chemical and electrochemical fuel to enable 
endergonic reactions to occur. We describe systems already 
pioneered but also propose alternative pathways for metabolic 
energy conservation on the basis of known strategies employed 
by simple microbes. In the second part, we quantify the amount 
of ATP needed for a (minimal) synthetic cell to reproduce itself, 
while maintaining the same concentration of biomolecules in 
mother and daughter cells. We find that the majority of metabolic 
energy of our model cell is needed for protein synthesis and 
maintenance processes. In the third part we describe vesicle-
based systems to encapsulate the metabolic networks for 
energy conservation, and the real-time monitoring of the internal 
conditions by fluorescence-based sensors. We also indicate 
where hurdles are expected in the construction of ever more 
complex systems. 
1.1. Coupling of exergonic and endergonic reactions and 
measure of energy status 
All known forms of life use two forms of energy currency: ATP 
and electrochemical ion gradients. The amount of free energy 
released upon hydrolysis of ATP to ADP plus inorganic 
phosphate is the same as that of other nucleoside triphosphates 
such as GTP, CTP, UTP or TTP, but ATP (and to a lesser extent 
GTP) is predominantly used when chemical energy needs to be 
coupled to endergonic reactions or processes (i.e. to shift the 
equilibrium). The energy stored in ATP is given by the 
phosphorylation potential (ΔGp  or ΔGp /F):  
 
∆𝐺 = ∆𝐺 + 2.3𝑅𝑇𝑙𝑜𝑔
[ ][ ]
[ ]










   (mV) 
 
Similarly, electrochemical proton or sodium ion gradients are 
most often used to drive membrane-bound processes, even 
though other types of ion and solute gradients exist. The F0F1-
ATP synthase/hydrolase interconverts the free energy of the 
phosphorylation potential into an electrochemical proton gradient, 
hereafter referred to as proton motive force (Δp): 
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= ∆Ψ − Z∆pH   (mV)   Eq. 2 
 
where 2.3RT/F equals 58 mV (at T=298 K) and is abbreviated as 
Z; F is the Faraday constant, R the gas constant and T is the 
absolute temperature. ΔG0’ = -30.5 kJ/mol, and typically ΔGp 
ranges from -50 to -65 kJ/mol (or ΔGp/F varies from -520 to -670 
mV). A sodium motive force (Δs) can be formed in a similar 
manner: 
 




= ∆Ψ − Z∆pNa   (mV)  Eq. 3 
 
From a control perspective it can be desirable to connect ATP 
and ion fluxes through a single enzyme such as F0F1-ATP 
synthase/hydrolase, but there are no fundamental principles that 
prohibit the two forms of energy to be formed and regulated 
independent of each other. As far as we are aware there are no 
known free-living forms of life without ATP synthase/hydrolase, 
but a few bacterial obligate endosymbionts lack the enzyme 
complex[14] and rely on substrate-level phosphorylation for their 
ATP production.[15] 
2. Cell fueling systems 
Respiratory organisms use the F0F1-ATP synthase to form ATP, 
whereas fermentative bacteria use the enzyme to hydrolyse part 
of their ATP obtained in catabolic reactions to generate an 
electrochemical ion gradient. At thermodynamic equilibrium, the 
phosphorylation potential equals the proton motive force times 
the number of protons (n) translocated per ATP. In formula:  
 
∆
= 𝑛∆𝑝            Eq. 4 
  
This number is determined by the c-ring stoichiometry of ATP 
synthase/hydrolase and varies from 2.7 to 5, depending on the 
specific enzyme.[16] Some organisms exploit an F0F1-ATP 
synthase/hydrolase that translocates sodium ions instead of 
protons, hence the formation or utilization of a sodium motive 
force (Δs). In addition, most forms of life exploit so-called 
sodium-proton antiporters to interconvert Δp and Δs. 
 
The F1FO-ATP synthase complex is one of the engineering 
masterpieces in the cell. We briefly discuss two important 
aspects of the complex, first the c-ring stoichiometry and second 
the regulation. The architecture of the c-ring, that is, specifically 
the copy-number of the c-subunit differs per organism from 8 
copies for bovine mitochondria[17] to 15 copies in Spirulina 
platensis.[18] This leads to different proton-to-ATP ratios (Eq. 4). 
From an engineering point of view the high-speed gear (low 
copy-number) works well in organisms that are continuously 
exposed to a high proton motive force, like in the bovine 
mitochondria. A high copy number leads to a high torque gear, 
essential when the proton motive force is low, or variable.[19] 
 
Because the magnitude of the p and Gp varies and a cell 
needs both forms of metabolic energy above some threshold 
value, it is important to have regulation in place to restrict the 
directionality of operation. An important regulator of the bacterial 
F1FO-ATP synthase complex is the  subunit. Structural data for 
this domain exists for two distinct conformations in different 
organisms.[20,21] Tsunoda et al.[22] have used cross-links to trap 
the  subunit in both of these conformations in E. coli. They have 
then shown that in one conformation the synthase works in both 
directions, whereas in the other conformation the synthesis of 
ATP remains functional but the ATP hydrolysis is inhibited. 
Meyrat and von Ballmoos[23] have shown that high ATP/ADP 
ratios inhibit the ATP synthesis, preventing the proton motive 
force to be drained completely. These two regulatory 
mechanisms prevent futile cycling of the ATPase in either 
direction. 
 
In heterotrophs, the oxidation of organic carbon yields CO2 plus 
reducing equivalents such as NADH and FADH2. The 
subsequent oxidation of NADH and FADH2 results in the 
formation of an electrochemical proton gradient by the 
respiratory chain. The usage of the Δp by the F0F1-ATP synthase 
results in the synthesis of ATP, and the overall process is known 
as oxidative phosphorylation. This route to Δp and ATP 
formation is complex and requires numerous enzymes and 
cofactors. Nature offers alternative mechanisms to conserve 
metabolic energy through simple metabolic conversion 
(deamination of amino acids, oxidation of carboxylic acids) or 
the use of light. In the following sections we discuss a number of 
alternatives to oxidative phosphorylation for the synthesis of 
ATP. We focus on simple systems to ease application in 
synthetic cells. 
Figure 1. Arginine breakdown pathway Metabolic energy conservation by 
breakdown of arginine. (A) Schematic of the arginine breakdown pathway. 
ArcA, arginine deiminase; ArcB, ornithine transcarbamylase; ArcC, carbmate 
kinase; ArcD, arginine/ornithine antiporter. For every molecule of arginine 
imported, one molecule of ATP is produced, while the product ornithine is 
exchanged for arginine; NH3 (formed from NH4+) and CO2 diffuse out passively. 
(B) Structures of arginine, citrulline and ornithine at pH 7. 
2.1. Arginine breakdown pathway 
Deamination of arginine yields citrulline plus NH4+, which is 
catalyzed by the enzyme arginine deiminase. Subsequent 
phosphorolysis of citrulline by ornithine carbamoyltransferase 
yields ornithine plus carbamoyl phosphate, a reaction that is 
thermodynamically unfavorable (Keq ~ 10-5) but proceeds when 
the reaction products are drained. Carbamate kinase converts 
carbamoyl phosphate plus ADP into CO2, NH4+ and ATP (Fig. 
1A) and thereby conserves a large fraction of energy dissipated 
in the breakdown of the amino acid. Since the substrate arginine 
and product ornithine are structurally related (Fig. 1B), they can 
be transported by one and the same protein via a so-called 
antiport mechanism.[24] This property of coupling substrate and 
product fluxes is also possible in many other pathways and aids 
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Figure 2. Decarboxylation pathways Metabolic energy conservation by decarboxylation of carboxylic acids (and amino acids, see Table I). (A) Schematic of the 
oxaloacetate decarboxylase Na+ pump. For every molecule of oxaloacetate converted into pyruvate, 2 Na+ ions are pumped out, while one H+ is imported. The 
system thus generates an electrochemical sodium gradient (ΔΨ plus ΔpNa) and in theory a pH gradient inside acid relative to the outside. Since the outside 
volume is typically very large, the inverse ΔpH will only be formed if the cell density is high and the external buffering capacity is low. B, Biotin. (B) Schematic of 
the malolactic fermentation pathway. The decarboxylation of malate1- consumes a H+, while the product, lactic acid, can be either exchanged for malate1- (top) or 
diffuse passively across the membrane (bottom). Both malate1-/lactic acid exchange (top) and malate1- uniport (with lactic acid diffusion) (bottom) generate a ΔΨ 
(inside negative relative to the outside) and ΔpH (inside alkaline relative to the outside). 
breakdown pathway has been reconstituted in liposomes with 
ATP/ADP and pH sensors (Box I) in the vesicle lumen to report 
the synthesis of ATP and to monitor the changes in internal 
pH.[25] The system can sustain a constant level of ATP for many 
hours even when the load on the system is varied by the 
consumption of ATP for the uptake of solutes. 
The overall reaction equation indicates that protons are 
consumed in the breakdown of arginine but in the vesicle system 
the actual internal pH is determined by (i) the rate of ATP 
production and consumption; (ii) the relative flux through the 
entire pathway and a futile route leading to citrulline; (iii) the 
diffusion of NH3 out of the cell, leaving a proton behind for every 
NH4+ produced; and (iv) the fate of CO2.  
Ad (i)  The synthesis of ATP is given by ADP3- + HPO42- + H+ 
ATP4- + H2O. Thus, a proton is consumed in the 
synthesis and produced in the hydrolysis of ATP. 
Ad (ii)  The antiporter is not entirely specific for ornithine but 
also exchanges arginine for citrulline (not shown in 
the figure), creating a futile deamination route through 
the action of ArcA and ArcD. 
Ad (iii)  NH3 can leave the vesicles by passive diffusion, 
which will leave a proton behind; the base/conjugated 
acid reaction of ammonia (NH4+ ↔ NH3 + H+; pKA of 
9.1) is fast. 
Ad (iv) CO2 can leave the vesicles by passive diffusion, but a 
high concentration of inorganic phosphate allows the 
formation of HCO3- and a proton, even in the absence 
of carbonic anhydrase. 
 
Because the import of arginine and efflux of ornithine are 
coupled and NH3 and CO2 can diffuse out, the membrane-
reconstituted arginine breakdown pathway constitutes an open 
system that enables long-term synthesis of ATP. A similar 
pathway can be envisaged in vesicles by employing the 
enzymes that convert agmatine into putrescine, CO2 plus 2NH4+, 
which also yields one ATP per substrate metabolized. 
2.2. Decarboxylation pathways 
The free energy released in the decarboxylation of dicarboxylic 
acids and amino acids is around -20 kJ/mol (Table I),[40] which is 
too little to directly make ATP from ADP plus inorganic 
phosphate (vide supra). The free energy change of a 
decarboxylation reaction can be stored in the form of an 
electrochemical ion gradient, which subsequently can be used to 
synthesize ATP  
Table 1. Overview of decarboxylation systems. Antiport refers to the exchange 
of the indicated substrate and product. The net predominant charge of the 
molecules at pH 7 is indicated.  
Substrate Product Transport 
mechanism 
Reference 
Malonate2- Acetate1- Electrogenic 
Na+ pump 
Berg et al 1997[26] 
Oxaloacetate2- Pyruvate1- Electrogenic 
Na+ pump 
Dimroth, 1982[27] 
Succinate2- Propionate1- Electrogenic 
Na+ pump 
Hilpert et al 1984[28] 
    
Oxalate2- Formate1- Antiport Anantharam et al 
1989 [29] 
Hirai et al 2002[30] 
Malate2- Lactate1- Antiport 
H-Malate- 
Uniport + lactic 
acid diffusion 
Poolman et al, 
1991[31] 
Salema et al 1994; 
1996[32,33] 
Arginine1+ Agmatine2+ Antiport Ilgü et al 2016[34] 
Glutamate1- γ-amino 
butyric acid0 
Antiport Richard et al 
2004[35] 
Ma et al 2012[36] 
Histidine0 Histamine1+ Antiport Molenaar et al, 
1993[37] 
Lysine1+  Cadaverine2+ Antiport Romano et al 
2013[38] 
Ornithine1+ Putrescine2+ Antiport Romano et al 
2013[38] 
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Figure 3. Artificial photosynthetic cells Schematic of artificial 
photosynthetic cell. Upon illumination, the vesicle synthesizes ATP by the 
coordinated activation of two complementary photoconverters (photosystem II, 
PSII and proteorhodopsin, PR) and an ATP synthase. PSII is activated by red 
light and acidifies the vesicle lumen, which allows the synthesis of ATP from 
ADP plus inorganic phosphate to take place on the outside. PR is activated by 
green light, which at low pH generates an electrochemical proton gradient, 
inside alkaline and negative, and thus impedes the synthesis of ATP. Figure 
taken with permission from [9]. 
(Eq. 4). Biochemical studies of decarboxylation reactions have 
shown two different mechanisms of energy conservation. In the 
first, the decarboxylation energy is converted directly into an  
electrochemical Na+ gradient (Fig. 2A), as first shown for 
oxaloacetate decarboxylation by Peter Dimroth.[27] In the second 
mechanism, the substrate is decarboxylated and the substrate 
and product are exchanged across the membrane (Fig. 2B).[29,31] 
Since the substrate and product carry a different net charge 
(Table I), the antiport reaction generates a membrane potential. 
The chemistry of the decarboxylation reaction requires a proton, 
hence the formation of a pH gradient when the reaction is 
performed in confinement, i.e. inside a vesicle system. In a 
variation on this mechanism, it was demonstrated that 
monoanionic malate is taken up by uniport and the formed lactic 
acid leaves the vesicles by passive diffusion (Fig. 2B). In general, 
biological membranes are highly permeable for weak acids and 
passive fluxes are considerable, even when the ambient pH is 2-
3 pH units higher than the pKA of the relevant conjugate acid-
base pair.[41] The energetics of the antiport and uniport is the 
same, but kinetically it can be advantageous to use an antiport 
mechanism as the product gradient contributes to the driving 
force for the influx of substrate and vice versa. 
 
We have purified the malate/lactate antiporter and malolactic 
enzyme from Lactococcus lactis and reconstituted the system in 
synthetic lipid vesicles. A pH gradient and membrane potential 
are formed when the vesicles are supplied with L-malate. The 
co-reconstitution of the decarboxylation pathway together with 
the arginine breakdown pathway would represent two 
orthologous routes for metabolic energy conservation, allowing 
the synthetic cell to use both ATP and a proton motive force 
without the involvement of an ATP synthase/hydrolase. Table I 
shows that substrate/product antiport or exchange always 
involves a product that is more positively charged than the 
substrate, hence the ΔΨ formed is inside negative relative to 
outside. The decarboxylation reaction inside the vesicles results 
in a ΔpH inside alkaline relative to outside. The arginine 
breakdown pathway can lead to acidification when citrulline is 
formed, but by combining the arginine breakdown pathway with 
the decarboxylation pathway it should be possible to better 
maintain a neutral to slightly alkaline internal pH. 
2.3. Artificial photosynthetic cells 
Numerous groups have co-reconstituted F0F1-ATP synthase with 
bacteriorhodopsin to control the synthesis of ATP by light. A 
disadvantage of this system is that the orientation of the proteins 
in the membrane is difficult to control. Recently, more advanced 
systems have been built with the aim of maintaining and 
controlling the electrochemical proton gradient. Shin and 
colleagues used the ATP synthase with two photoconverters, a 
photosystem II and proteorhodopsin.[9] The three proteins were 
reconstituted in small lipid vesicles (“artificial organelles”) with 
the F1 domain of the ATP synthase on the outside (Fig. 3). Upon 
activation of photosystem II by red light protons are pumped into 
the vesicles (the interior becomes positive and acidic), and the 
Δp drives the synthesis of ATP. Activation of proteorhodopsin by 
green light dissipates the Δp or even reverses the polarity of the 
electrochemical proton gradient, which impedes the synthesis of 
ATP. The artificial organelles were encapsulated in giant 
vesicles to provide them with ATP and drive endergonic 
reactions, such as pyruvate carboxylase-mediated carbon 
fixation and actin polymerization. 
 
In another study, ATP synthase and bacteriorhodopsin were 
incorporated in small vesicles and used to drive protein 
synthesis in giant-unilamellar vesicles.[42] Remarkably, part of 
the de novo synthesized bacteriorhodopsin and ATP synthase 
were integrated into the artificial photosynthetic organelle and 
thereby enhanced the energetic capacity of the system. The 
proteins are synthesized by the components of the PURE 
system, but the machinery (Sec, YidC) for insertion of proteins 
into the membrane is missing. It remains to be established how 
the membrane proteins are (spontaneously) inserted in the 
artificial organelle membrane. 
2.4. Molecular rheostat 
In the arginine breakdown pathway, a remarkable degree of 
energy homeostasis is achieved, but the actual ATP level is 
influenced by the amount of ATP demanding reactions.[25] Bowie 
and colleagues have described a molecular rheostat that 
accounts for the ATP demand through switching between an 
ATP-generating and non-ATP-generating pathway according to 
the concentration of inorganic phosphate (Fig. 4, taken from [5]). 
The system is based on fourteen purified enzymes in a cell-free 
system and used to produce in solution isobutanol from glucose. 
The breakdown of glucose is branched at the level of 
glyceraldehyde-phosphate dehydrogenase (GAPdh) to make the 
use of NADH and ATP stoichiometrically balanced. In brief, in 
one branch the glyceraldehyde-3-phosphate (G3P) is 
metabolized via.GAPdh and phosphoglycerate kinase (PGK), 
yielding ATP and reducing equivalents. In the other branch G3P 
is converted via a non-phosphorylating glyceraldehyde 
dehydrogenase (GapN). GapN eliminates the production of ATP 
and generates NADPH rather than NADH, which is needed for 
the production of 2-ketoacid isobutanol. The relative flow 
through the ATP-generating branch is set by the concentration 
of inorganic phosphate, which is a substrate of GAPdh but not of 
GapN. Hence, the rheostat responds to the depletion of ATP 
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Figure 4. Molecular rheostat to control the ATP and NAD(P)H levels 
Schematic of the operation of the molecular rheostat. Left panel: at low Pi 
concentrations and high levels of ATP, the GapN pathway is used which 
generates no additional ATP. Right panel: at high Pi concentrations (resulting 
from the hydrolysis of ATP), the mGapDH– PGK pathway is used to restore 
the ATP level. G3P, glyceraldehyde-3 phosphate; 3PG, 3-phosphoglycerate; 
1,3-BPG, 1,3-bisphosphoglycerate. Figure taken with permission from [5] 
3. Compartmentalization and vesicle systems 
3.1. Building blocks for membranes 
One of the hallmarks of living species is compartmentalization, 
which implies that membrane-bounded systems may have 
arisen early on in the emergence life.[43] Compartmentalization in 
the form of vesicles allows molecules to concentrate, interact 
and coevolve, which is a conditio sine qua non for life. Vesicle 
structures can form spontaneously from fatty acids, as first 
reported in 1973,[44] and such membranes may have surrounded 
the first cells. Fatty acid-based vesicles are capable of growth 
and division when the appropriate components are added to the 
medium or the right physical conditions are imposed,[45,46] but 
they are less stable and more permeable to small molecules 
than conventional phospholipid-based membranes. Fatty acid-
phospholipid blended membranes display increased stability but 
still maintain permeability for small (charged) solutes. They may 
have formed an intermediate in protocellular evolution, which 
allowed membrane passage without transporters.[47]  
 
Well-sealed, stable membranes can also be formed from block 
copolymers,[48] but the functional incorporation of integral 
membrane proteins is challenging, especially when the proteins 
require specific lipids as cofactors. The majority of successful 
reconstitutions in non-native-amphiphile membranes involve 
relatively stable membrane pores or channels that do not 
undergo large conformational changes in the membrane.[49] 
Functional reconstitution of more complex enzyme systems has 
been achieved by using a blend of phospholipids and a block 
copolymer to stabilize the activity of the protein.[50]  Today’s 
biological membranes are mostly composed of lipids, in which 
proteins are embedded. Even if the reconstitution of complex 
membrane proteins in a block copolymer lipid blend would be 
possible, the synthesis (and incorporation) of block copolymers 
in a growing cell would require biochemical machinery that does 
not exist in organisms know today. Most vesicle systems for 
functional reconstitution use phospholipids.  
 
We have studied numerous membrane transporters, both ATP-
and electrochemical ion gradient-driven, and find that anionic 
lipids (phosphatidylglycerol or phosphatidylserine) and the non-
bilayer lipid phosphatidylethanolamine are generally required for 
activity.[51] Many eukaryotic proteins require sterols for full 
functionality and cholesterol (mammalian), ergosterol (yeast) or  
plant-based sterols can be included in the reconstitution 
mixture.[52] For the hydrophobic chains we typically use 1,2-
dioleoyl (diC18:1 Δ9-cis) or 1-palmitoyl-2-oleoyl (C16:0, C18:1 
Δ9-cis), thus DOPX and POPX, respectively. DOPX membranes 
have a lower phase transition temperature and are less stable 
and more permeable for small molecules than POPX 
membranes.[41] Both at the level of lipid mixtures and at the level 
of blends between lipids and fatty acids or block copolymers, 
there is still a lot to be learned to enable (more) complex 
reconstitution of synthetic cell-like systems. 
3.2. Membrane crowding 
Biological membranes are highly crowded with proteins and thus 
the lipid-to-protein ratios are low; in the plane of the membrane 
only a few lipids separate individual protein complexes. For 
example, the weight-based lipid-to-protein ratio of the plasma 
membrane is about 1[53], which leaves about fifty lipids per leaflet 
to cover the perimeter of a 70kDa protein. Given that membrane 
proteins perturb the dynamics of lipids, a crowded biological 
membrane will be more rigid and less fluid than that of “dilute” 
liposomes, in which proteins are typically present at lipid-to-
protein ratios of 10 to 1000 (w/w), corresponding to molar ratios 
of 1000 to 100,000. In synthetic vesicles with 2000 rather than 
10,000 or more phospholipids per membrane protein (complex), 
the diffusion coefficient of lipids is already reduced by 20% and 
that of polytopic membrane proteins by 50%,[54] which is 
indicative of a lower fluidity or higher lipid order in the membrane. 
A lower fluidity may impact the (detergent-mediated) insertion of 
a protein into the membrane, which is the commonly used 
method of membrane reconstitution.[51,55] In fact, we find that the 
activity of membrane transport proteins does not increase 
proportionally with the amount of protein used for the 
reconstitution when the lipid-to-protein ratios fall below 2000 
(mol/mol) .[56] This ratio corresponds to about 1500 proteins per 
µm2 [54] and compares to 25,000 proteins per µm2 in native 
plasma membranes. Apparently, not all proteins are correctly 
inserted into the membrane when the lipid-to-protein ratio drops 
below 2000. 
 
Thus, our reconstitution technology may become a bottleneck in 
the bottom-up construction of synthetic cells when (multiple) 
proteins need to be incorporated at high concentrations. 
Ultimately, we will need protein insertion machineries like Sec[57] 
rather than detergent-destabilization of vesicles to build more 
complex systems. 
3.3. Vesicle systems 
Cell-sized aqueous compartments for synthetic cells range from 
submicrometer (large unilamellar vesicles, LUVs) to micrometer 
(giant-unilamellar vesicles, GUVs). Procedures have been 
developed to incorporate integral membrane proteins or lipid-
anchored proteins into the membrane and to include enzymes 
and small molecules into the vesicle lumen. We typically form 
LUVs via detergent-mediated reconstitution ,[51] which is based 
on a method originally developed by Jean-Louis Rigaud.[55] We 
have produced sub-micron and micrometer size 
proteoliposomes with up to 50 mg/ml of protein or cell lysate in 
the vesicle lumen,[58] but technically it is challenging to achieve 
in vivo-like crowding levels (200-300 mg/mL).[59] By increasing 
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Figure 5. Building blocks for information carriers Synthesis of nucleotide triphosphates. (A) Simplified reaction diagram for the synthesis of ATP, GTP, UTP 
and CTP. After ribose-5-phosphate is converted into phosphoribosyl pyrophosphate (PRPP), it is converted in ten steps into inosine monophosphate (IMP) to form 
ATP and GTP. PRPP plus orotate yields orotidine 5’-monophosphate (OMP), which is converted in two steps into UTP and CTP. Gln, glutamine; Glu, glutamate; 
Asp, aspartate; THF, tetrahydrofolate. (B) Chemical structures of PRPP, OMP and IMP. 
 
 
the luminal contents are concentrated. The shrinking of the 
vesicles is reversible, which occurs when osmolytes are taken 
up or the outside osmolality is reduced.[25] In this way one can 
study synthetic metabolic networks under varying conditions of 
crowding, ionic strength and osmotic pressure. 
 
The sub-µm size lipid vesicles are robust and suitable for 
ensemble measurements of solute import, cargo release, and 
single-liposome analysis of vesicle size and swelling,[60] and 
recently LUVs have been used to reconstitute a metabolic 
network for energy and physicochemical homeostasis.[25] 
Although LUVs are small, they have dimensions similar to that of 
small, free-living bacteria such as Pelagibacter, and thus their 
volume should not pose a hurdle for accommodating all the 
essential components of a cell (see Section 4). The µm-size 
GUVs are more fragile but offer the advantage that they can be 
used for patch clamp and light microscopy studies. Membrane 
domain formation, the dynamics of individual molecules and 
their possible interaction with other membrane components can 
be tracked.[61] In the context of bottom-up synthetic biology 
GUVs have been used as platform to develop artificial 
photosynthetic organelles,[9] synthetic beta-cells[62] and motile 




3.4. A metabolic network for energy and physicochemical 
homeostasis 
Any living cell maintains the pH, ionic strength, osmotic pressure, 
macromolecular crowding and ΔGp within limits to allow the 
enzymes and other components to function near their optimum. 
Hence, the importance to obtain physicochemical homeostasis 
in cell-like systems. The arginine breakdown pathway has been 
co-reconstituted with an ionic strength-gated ATP-driven 
osmolyte transporter to allow vesicle expansion and restoration 
of the physical chemical conditions upon exposure to osmotic 
stress.[25] When the vesicles are exposed to an increasing 
medium osmolality, they shrink and the ionic strength increases 
and the concentrations of the internal components are increased.  
Under these conditions the pathway functions suboptimally and 
the enzymes are gradually inactivated. However, when the ionic 
strength reaches a critical value, the ATP-driven osmolyte 
transporter is activated and glycine betaine is pumped inside, 
which is accompanied by passive influx of water into the vesicles. 
This increases the volume, reduces the ionic strength and 
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4. How much ATP does a synthetic cell need? 
One of the essential design factors of synthetic cells is the 
amount of energy required for the cell to perform its (core) 
functions. As an example, in E. coli the ATP turnover is a few 
million molecules per second, given that the ATP pool is turned 
over 4 to 7.5 times per second[64], a volume of 1 fL[65] and an 
internal ATP concentration of 10mM[65]. In section 4, we 
elaborate on the energy requirements of a hypothetical synthetic 
cell, focusing on the quantification of the ATP-consuming 
reactions. First, we list important energy requiring processes, 
and in the second part we make a quantification of the ATP 
equivalents needed to operate a synthetic cell. We list all energy 
used by a cell in terms of ATP equivalents (Table 2) as it takes 
one ATP to regenerate GDP (or any other nucleotide-
diphosphate) to the triphosphate form by a nucleoside-
diphosphate kinase. We estimate that of all nucleotides turned 
over about 80% is in the form of ATP. 
4.1. Proteins 
In bacteria, the vast majority of all ATP (around 75%) is used for 
the synthesis of proteins.[66] Most of that energy is used for the 
synthesis of ribosomes and formation of the peptide bond. The 
energy that is used for synthesis of amino acids, can be 
minimized by taking up amino acids in the form of di- or 
tripeptides, followed by internal digestion through peptidases. 
The membrane transporter DtpT takes up virtually every di- or 
tripeptide together with one or multiple protons, driven by Δp.[67] 
An alternative broad specificity transporter Opp, belonging to the 
ABC superfamily, imports oligopeptides with lengths between 4-
35 amino acids,[68] likely using 2 ATP equivalents per 
oligopeptide. Digestion of these di, tri or oligopeptides into amino 
acids can then be done by amino- and endopeptidases, without 
additional energy cost. This lowers the metabolic energy cost for 
synthesis of amino acids to less than 1 ATP per amino acid. 
Forming a new peptide bond however requires approximately 4 
ATP equivalents. Two ATP equivalents for amino acid activation, 
one ATP equivalent for aminoacyl-tRNA binding to the 
elongation factor and finally one ATP equivalent for the 
translocation reaction, where the peptidyl-tRNA is translocated 
from the A-site to the P-site.[69,70] 
4.2. Information carriers 
Nucleotides for information carriers can be synthesized de novo, 
using approximately 50 ATP equivalents per nucleotide.[71] The 
energy costs are lower when a simpler route is used (Fig. 5) and 
the necessary amino acids are imported (section 3.1). The 
energy cost of the simplified pathway is around 10 ATP 
equivalents per nucleotide (Fig. 5). Here, the conversion of 
ribose-5-Pi, carbamoyl phosphate and amino acids to the final 
products (ATP, GTP UTP and CTP) requires around 20 
enzymatic steps, which is manageable from an engineering 
perspective. The main drawback of de novo nucleotide synthesis 
is that it comes with the complex regulation of pathways and the 
underlying biochemistry of different components.  
 
An even simpler solution than outlined in Figure 5 is to take up 
the nucleotides directly from the environment, a solution used by 
pathogens that lost their ability to synthesize their nucleotides.[72] 
By for example using a combination of the nucleotide carriers 
PamNTT3 and PamNTT5, the nucleotides UTP, GTP and ATP 
can be taken up with Δp as a driving force.[73] UTP can then be 
converted into CTP, using one ATP equivalent in a single 
enzymatic step. After the nucleotide-triphosphates are converted 
by nucleoside-diphosphate kinase into nucleotide-diphosphates, 
they can then be turned into their respective 
deoxyribonucleotides analogues. Using this strategy, the 
nucleotides can be produced by a minimal set of enzymes 
requiring less than 3 ATP equivalents per nucleotide. dUMP can 
be converted into dTMP by a thymidylate synthetase, after which 
dTMP is converted into dTTP. Apart from the metabolic energy 
cost for synthesis or and import of nucleotides, the formation 
and maintenance of DNA and RNA have additional energy costs. 
For DNA, the error correction is estimated to require one ATP 
equivalent per built-in nucleotide.[71] For mRNA, the degradation 
rate needs to be considered, as the lifetime of for instance 
mRNA is shorter than the cell cycle. When mRNA is degraded, 
the nucleotides can be recycled, which takes 2 ATP equivalents 
per nucleotide.[71] 
4.3. Lipid synthesis for compartmentalization 
The minimal lipid composition of a synthetic cell consists of 50% 
DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) plus 
50% DOPG (1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol)). 
This lipid composition supports high rates of transport of the 
bacterial transporters that we have studied; for eukaryotic 
membrane proteins a sterol and some specific lipids may be 
required (see section 4.1), which we do not consider here. 
Synthesis of these lipids, or similar ones with different acyl 
chains (e.g. POPE and POPG), can be performed by combining 
a set of around ten enzymes.[74] Starting from oleic acid and 
glycerol, the intermediate CDP-DAG is formed in four enzymatic 
steps, after which further conversion yields either DOPE or 
DOPG (Fig. 6). Coenzyme A is required for the lipid synthesis 
but is also regenerated by FadD. The initial amount of coenzyme 
A can be synthesized de novo from pantothenate, or imported 
using an acetyl-CoA transporter, e.g. ACATN1.[75] In total the 
synthesis of DOPE and DOPG by this pathway takes 7 and 8 
ATP equivalents per lipid, respectively. Adding a lipid 
scramblase would enforce the lipids to distribute over both the 
inner and outer leaflets.[76]  
4.4. Membrane transport for osmotic, ionic and pH control 
Growing (synthetic) cells should maintain their osmolarity, ionic 
strength, and pH in order to keep the cellular machinery active 
and maintain a stable, out-of-equilibrium state. Therefore, import 
of ions, compatible solutes and inorganic phosphate (Pi) is 
crucial. The most abundant ions in cells are K+ (30-300 mM) and 
Mg2+ (30-100 mM) as cations, and inorganic and organic 
phosphates (~100 mM), glutamate (100mM), RNA, DNA and 
proteins as anions.[65] Except for RNA, DNA and proteins these 
ions need to be taken up by membrane transporters, mostly 
driven by Δp e.g. the phosphate transporters of the PiT family[77]; 
ATP e.g. the high affinity potassium uptake system Kdp[78]; or 
both e.g. the Trk potassium uptake system.[79] Here, for 
simplicity we count one ATP per ion that is taken up. 
4.5. Maintenance energy 
Maintenance costs cover the energy that is spent on anything 
that is not directly related to growth. For example: energy loss in 
futile cycling of enzymes, leakage of compounds over the 
membrane or processes like adaptation, e.g. pH and 
osmoregulation to keep the cytosolic conditions right. The 
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Box I. Sensors to measure the energy and physicochemical status of cells 
Several genetically encoded sensors and chemical probes are available to monitor the energy and redox status and physicochemical 
conditions of synthetic cells. Here, we describe some generic sensors used in our synthetic biochemistry program; numerous solute-specific 
sensors are described in references [80,81]  
ATP: The ATeam sensors are FRET based and consist of two fluorescent proteins (FPs), which are connected by the ε-subunit of the F0F1-
ATP synthase from Bacillus subtilis.[82] Upon binding of ATP the ε-subunit adopts a compact conformation and draws the two fluorophores 
closer together, increasing the FRET ratio. Three variants are available with high and low affinity for ATP, and a version that does not bind 
ATP. A single fluorophore variant has been developed in which the readout is provided by a single circular permutated FP.[83] PercevalHR  
binds ATP and ADP with similar, micromolar affinities. At physiological levels of adenine nucleotides PercevalHR is practically fully saturated 
with ligand and therefore reports the ATP to ADP ratio rather than the absolute concentration of ATP or ADP.[84] As in the Queen sensors, a 
circular permutated FP allows ratiometric readout. Lastly, based on Queen, an intensiometric ATP sensor was developed which can be bound 
to the membrane.[85]  
NAD(P)H: SoNar is a ratiometric genetically encoded sensor that reports the NAD+ to NADH ratio.[86] iNap is a derivative of SoNar and reports 
the NADPH concentration instead of the ratio between NADP+ and NADPH.[87] 
pH: pHluorin and pHred are protein-based pH sensors.[88,89] pHluorin is based on GFP and has spectral properties in the yellow and green 
region. pHred is based on mKeima and is, owing to its large stokes shift, compatible with the ATP sensor PercevalHR. In addition to protein-
based sensors, chemical probes are available like pyranine and BCECF.[90,91] These are commercially available and allow imaging for longer 
periods of time than the protein-based sensors. Methyl-ester derivatives of BCECF readily permeate the plasma membrane, and in the 
cytosol the molecules become trapped upon hydrolysis of the ester bond (esterase activity). Given the value of the external pH, 
measurements of the internal pH enable calculation of the magnitude of the ΔpH across the membrane. 
Membrane potential: The membrane potential (ΔΨ) is measured by chemical probes, like diSC3-5.[92] The exact mechanism of how diSC3-5 
reports changes in the ΔΨ is not fully understood, but its fluorescent intensity increases upon interaction with lipid membranes. This 
fluorescence is quenched upon polarization of the membrane. The magnitude of the proton motive force is obtained by combining the ΔΨ & 
ΔpH, according to equation 2. 
Ionic strength: The ionic strength is measured with a FRET sensor that consists of two fluorescent proteins joined by a flexible linker and two 
α-helices with opposite charges.[93] The FRET signal is high when the ionic strength is low, and the signal is low when a high ionic strength of 
the solution shields the charges of the α-helices. 
Excluded volume: The excluded volume or so-called macromolecular crowding sensors have a similar design as the ionic strength sensor, 
except that the same charge pairs are present on both α-helices. Here, the excluded volume drives a more compact state of the sensor, 
which is observed as an increase in FRET signal.[94,95] A similar crowding-sensing principle was used in a synthetic sensor; here, two 
chemical fluorophores forming a FRET pair are connected by a polyethylene polymer linker.[96] 
Viscosity: Viscosity is measured by fluorescent molecular rotors. These rely on intra-molecular rotation, which is suppressed by a high 
viscosity, which results in increased fluorescence. Fluorescent molecular rotors are available as intensio- and ratiometric sensors.[97,98] 
Potassium: KIRIN1/KIRIN-GR and GINKO1 are potassium ion sensors that are based on the same K+ binding protein, but differ in the 
fluorescent proteins used. The two KIRIN sensors use different FRET pairs, whereas GINKO1 has only one circular permutated FP.[99] They 
report potassium concentrations in the low millimolar range. 
 
Parameter Name Fluorophore Read-out Spectral maxima (nm) Comments 
excitation emission 
ATP Ateam CFP mVenus Ratiometric FRET 435 475 527 Moderately pH sensitive 
ATP Queen cpEGFP Ratiometric 400 494 513 Moderately pH sensitive 
ATP/ADP PercevalHR cpmVenus Ratiometric 420 500 515 pH sensitive 
ATP iATPSnFR cpSFGFP Intensiometric 490 512 Ratiometric when fused 
to mRuby, moderately 
pH sensitive 
NAD+/NADH  SoNar cpYFP Ratiometric 420 485 530 pH insensitive 
NADPH iNAP cpYFP Ratiometric 420 485 530 pH insensitive 
pH pHluorin GFP Ratiometric 410 470 535 Intensiometric variant 
available 
pH pHred mKeima Ratiometric 440 585 610 Compatible with 
PercevalHR 
pH pyranine Arylsulfonate Ratiometric 400 450 510 Commercially available 
pH BCECF fluorescein Ratiometric 439 490 530 Commercially available 
Ionic Strength I-sensor Cerulean Citrine Ratiometric FRET 420 475 525 Different designs 
available 
Excluded volume Crowding sensor Cerulean Citrine Ratiometric FRET 420 475 525 Sensors differing in 
crowding sensitivity are 
available; different 
designs available 
Excluded volume Synthetic 
crowding sensor 




DiSC3-5 carbocyanine Intensiometric 653 676 Commercially available 
Viscosity Various 




K+ KIRIN1 mCerulean3 
cpVenus 
Ratiometric FRET 410 475 530 Selective for K+ over Na+ 
K+ KIRIN-GR Clover mRuby2 Ratiometric FRET 470 520 600 Small FRET change 
K+ GINKO1 EGFP Ratiometric 400 500 520 Sensitive to high 
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Figure 6. Lipid biosynthesis Synthesis of two major phospholipids, DOPG and DOPE. (A) Reaction diagram for the synthesis of 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPG) and 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG) from the precursors glycerol, oleic acid and serine. Both glycerol 
and oleic acid (OA) can diffuse across the membrane, after which they are converted into glycerol 3-phosphate (G3P) and acyl-coenzyme A (acyl-CoA), 
respectively. Two molecules of acyl-CoA react with G3P to form 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA), from which DOPE and DOPG can be formed in 
three steps. CDP-DAG, cytidine diphosphate diacylglycerol. Phospholipids with alternative acyl chains can be synthesized by feeding the synthetic cell with the 
appropriate fatty acids. (B) Chemical structures of glycerol and oleic acid (OA). 
 
(uptake) at various growth rates by extrapolation to zero 
growth. Measurement or quantification of this parameter is 
not straightforward, since it varies depending on the specific 
metabolism. Feist et al. report, based on a metabolic 
reconstruction of aerobically growing E. coli cells, a non-
growth associated maintenance (NGAM) of 8.4 ATP/gDW/h, 
while the growth associated energy costs are 59.8 
ATP/gDW/h.[100] If we take the weight of one E. coli to be 1 
pg[65] the ATP consumption for NGAM of a single cell is 
4.8•109 ATP equivalents per hour compared to 3.4•1010 ATP 
equivalents for the growth-associated costs.  
4.6. Quantification of ATP demand of minimal synthetic 
cell 
To quantify the energy requirement of a synthetic cell, we 
assume a spherical cell with a diameter of 400 nm and a 
volume of 0.03 fL, a size comparable to the size of the 
smallest free-living micro-organisms known today.[101] To 
estimate the protein content, we assume that the crowding is 
comparable to that of e.g. E. coli, which has approximately 
3•106 proteins per µm3 and a volume of about 1 fL.[65] A 
synthetic cell with a volume of 0.03 fl would thus contain 105 
proteins. The average protein has a length of 300 amino 
acids and costs 5 ATP equivalents per amino acid. If we 
assume that the lifetime of a protein is longer than the cell 
cycle then the synthesis of all proteins takes 1.5•108 ATP 
equivalents.  
 
We quantify the DNA replication and transcription by taking a 
genome size of 500 genes, similar to the genome of JCVI-syn 
3.0.[3] We take an average gene length of 900 base pairs (300 
amino acid protein and minimal intergenic DNA) and thus the 
genome would consist of 4.5•105 base pairs. Taking 3 ATP 
equivalents per nucleotide, the total energy cost for the 
genome would be 3.6•106 molecules of ATP. 
 
The cost of transcription depends on the total RNA level, 
which for E. coli can be estimated at 103-104 copies per 
cell.[65] Following the same calculation, we estimate the 
synthetic cell to have 20-200 copies per cell, based on the 
aforementioned protein concentration and a doubling time of 
an hour. Since this would mean less than one transcript per 
protein we take a number of 500 copies per cell, which is 
equal to the protein number. If we take a degradation rate of 
10-3 copies s-1 the total ATP consumption would be 4.6•106 
ATP equivalents.[71] For rRNA and tRNA we take 1.0•103 and 
1.3•104 copies[65] leading to an energy cost of 1.4•107 and 
3.4•106 ATP equivalents, respectively. 
 
The synthetic cell, spherical with a diameter of 400nm, has a 
surface area of 5•105 nm2 requiring a bilayer of 1.5•106 
phospholipids, assuming an area per lipid of 0.7 nm2. The 
lipid synthesis starting from fatty acids, takes 7.5 ATP 
equivalents per lipid if we take a composition of 50% DOPE 
plus 50% DOPG. Thus, it would take 1.1•107 ATP equivalents 
to synthesize all lipids.  
 
ATP required for transport and maintenance can be estimated 
as follows. If we sum all ions and solutes needed for 
maintaining the internal osmotic pressure, ionic strength and 
metabolite pool (260-600mM) and assume that uptake of 
each molecule costs one ATP, then a cell with a volume of 
0.03 fL would consume 0.5 – 1.1•107 ATP equivalents. A 
single E. coli uses 4.8•109 ATP per hour for non-growth 
associated maintenance (see above). Assuming that this 
scales with cell volume, the synthetic cell requires 30 times 
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We think that the amount of ATP required for cell division is 
small compared to that of the other processes considered. 
The absolute amount of ATP is difficult to estimate, FtsZ 
being a dynamic system.[102] Taking estimations from Dr. DJ 
Scheffers (personal communication), 20.000 FtsZ per E. coli 
with a turnover of 1.5 GTP/min gives 7.5•105 GTP (or ATP-
equivalents) per doubling (25 minutes.). For our synthetic cell 
with a doubling time of an hour and a volume that is 30 times 
smaller we estimate 6.0•104 ATP equivalents. 
 
In Table II we compare the categorized ATP consumption of 
our hypothetical synthetic cell with that of E. coli.[103] We find 
as expected that a major fraction of the ATP is needed for the 
synthesis of protein, and surprisingly a similar amount of ATP 
is used for maintenance. In the synthetic cell the ATP needed 
for maintenance is based maintenance in E. coli, which is a 
much more complex organism than the synthetic cell, 
therefore scaling only to volume might well lead to an 
overestimation.  
 
Table 2. ATP requirements of the major cellular processes. The data for E. 
coli in mmol/gram dry weight were taken from [103] and converted into ATP 
equivalents per cell, asuming a cytoplasmic volume of 1 fL. The synthetic 
cell data are based on a spherical cell-like system with a volume 0.03 fL. 
The quantification of the ATP costs for this system is described in section 
4.6.  






E. coli                
(ATP 
equivalents) 
Protein    
- Uptake of 
amino acids 
3.0•107 (8%)   
- Glucose to 
amino acids 
 1.4 8.0•108 
- Translation 1.2•108 (34%) 19.1 1.1•1010 
DNA 3.6•106 (1%) 1.1 6.3•108 
RNA  4.4 3.3•109 
mRNA 4.6•106 (1%)   
tRNA 3.4•106 (1%)   
rRNA 1.4•107 (4%)   




1.1•107 (3%) 5.2 3.0•109 
Maintenance 1.6•108 (45%)  4.8•109 * 
Division 6.0•104 (0%)  7.5•105 ** 
* Maintenance from [100] ** Estimation by Dr. DJ Scheffers (see text). 
 
 
5. Outlook and Perspectives 
The construction of a living cell from molecular components is 
one of the major challenges of today’s chemistry and life 
sciences, as one is crossing the border from the ‘dead’ 
molecules of chemistry to the living systems of biology. It has 
not yet been possible to rationally design and construct, using 
a bottom-up constructive approach, a simple form of life 
based on a limited number of molecular building blocks. While 
our fundamental understanding of the individual building 
blocks of life is rapidly growing, putting a minimal set of 
components together such that life-like properties emerge 
remains a formidable, yet exciting challenge. 
 
Non-equilibrium systems are driven by the continuous flow of 
energy and matter and can develop into a multitude of states, 
e.g. when the flow of matter is perturbed. Nature is an 
assemblage of many of such open systems, each of which 
can take its own path. The challenge is to construct and 
control such systems. In this paper, we have presented an 
overview of the simplest systems one could envisage to 
sustainably supply a cell with fuel in the form of ATP and/or 
electrochemical ion gradients. By coupling the energy feed to 
product export, it is possible to maintain a continuous flow of 
in the pathways for ATP or ion gradient formation. One of the 
bottlenecks in current systems is that one or a few 
components, for instance ATP, runs out, leading the system 
to equilibrium. We have recently shown that it is possible to 
use the provision and consumption of ATP for 
physicochemical homeostasis in synthetic vesicles. The next 
challenge is to couple the metabolic energy conservation to 
synthetic modules for e.g. lipid, protein, and nucleic acid 
synthesis (Fig. 5), yet maintain energy and physicochemical 
homeostasis. Ultimately, the synthesis of the components 
needs to be directed by a synthetic genome, and we need to 
coordinate DNA replication with growth and division. In Box II 
we present a series of outstanding questions on fuel supply 
and homeostasis of metabolic energy in synthetic cells. 
 
Box II. Open questions 
1. Is the interconversion of ATP and electrochemical ion via 
ATPsynthase /hydrolase essential for life? 
2. How much ATP is required for polymer synthesis and 
maintenance processes in small cell-like systems? 
3. What is the lower limit in size for a cell? 
4. What are the physicochemical limits for life of e.g. ionic 
strength or macromolecular crowding? 
5. How can we increase the efficiency of membrane 
reconstitution and molecule encapsulation to build more 
complex cell-like systems? 
6. Bridging the gap between bottom up and top down. What do 
we know? 
7. How many unknown components are there still to be 
discovered? 
8. How can we use bio-orthogonal systems in living systems? 
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